| (Values in U.S. Thousands) | Feb, 2023 | Nov, 2022 | Aug, 2022 | May, 2022 | Feb, 2022 |
| Sales | 0 | 10 | 30 | 170 | 80 |
| Sales Growth | -100.00% | -66.67% | -82.35% | +112.50% | -20.00% |
| Net Income | -720 | 2,300 | -800 | -1,270 | -2,290 |
| Net Income Growth | -131.30% | +387.50% | +37.01% | +44.54% | -10.63% |
Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York.
Fiscal Year End Date: 11/30